Join
Live feed
·
INSIDERFilingvia Quantisnow
Protalix BioTherapeutics Inc. (DE) logo

SEC Form 4: Bashan Dror bought $102,000 worth of shares (68,000 units at $1.50)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PLX (Protalix BioTherapeutics Inc. (DE)) and more on Quantisnow.